Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Gurnari, C; Makishima, H; Durmaz, A; Attardi, E; Saiki, R; Bataller, A; Sapinho, G; Gondek, L; Nannya, Y; Best, S; Krishnamurthy, P; Kong, KL; Atsuta, Y; Kasahara, S; Ohyashiki, K; Miyazaki, Y; Kanemura, N; Hiramoto, N; Versino, F; Montoro, MJ; Torres-Esquius, S; Cayuela, AJ; Lopez-Esteban, M; Martínez-Laperche, C; Awada, H; Visconte, V; DiNardo, CD; Voso, MT; Dezern, AE; Garcia-Manero, G; Kulasekararaj, AG; Maciejewski, JP; Ogawa, S.

DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study

LEUKEMIA. 2025; 40(1): 178-187 Nº de citas: 5 [doi:10.1038/s41375-025-02814-0]

Martin-Moro, F; Bento, L; Marquet, J; Browne-Arthur, SF; Gutierrez, A; Diaz-Lopez, A; Sanchez-Pina, J; Garcia-Vela, JA; Salar, A; Cordoba, R; Novelli, S; Rodriguez-Salazar, MJ; De Villambrosia, SG; Del Campo, R; Luzardo, HD; Garcia, D; Garcia-Marco, JA; Sancho, JM; Abrisqueta, P; Martin, A; Grande, C; Lopez-Jimenez, J; Bastos-Oreiro, M.

Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI

ESMO Open. 2025; 10(12): [doi:10.1016/j.esmoop.2025.105873]

Carbonell, D; Rodríguez-Sosa, A; Gomez-Serrano, L; Pérez-Corral, A; Ruano, G; Galayo, M; Panadero, N; Rufián, L; Lorente, N; Rodríguez-Barquero, P; Domingo-Merino, D; Muñoz-Martínez, C; Kwon, M; Das, S; García-Sanz, R; Anguita, J.

Predictive biomarkers validation of CD3+ cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach

Scientific Reports. 2025; 15(1): [doi:10.1038/s41598-025-27061-2]

Sanz, J; Ferhat, AT; Raiola, AM; Blaise, D; Arat, M; Koc, Y; Benakli, M; Kwon, M; Kulagin, A; Parma, M; Sica, S; Tischer, J; Pavlu, J; Dhedin, N; Grillo, G; Kröger, N; Montoro, J; Giebel, S; Peric, Z; Savani, B; Nagler, A; Piemontese, S; Mohty, M; Ciceri, F.

Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT

BONE MARROW TRANSPLANTATION. 2025; 61(2): 166-171 [doi:10.1038/s41409-025-02763-3]

Rodríguez-Sánchez, B; Campos-Domínguez, M; Del Puerto, AD; Bernabeu-Wittel, J; Monserrat-García, MT; Arias-Lotto, F; Parra-Blanco, V; Beléndez-Bieler, C; García-Morín, M; Bardon-Cancho, E; Marco-Sánchez, JM; González-Gerrero, A; Baselga-Torres, E; Prat-Torres, C.

Post-Hematopoietic Stem Cell Transplantation Eczematous Dermatitis Spectrum Successfully Treated With Dupilumab: A Case Series and Review of the Literature

PEDIATRIC DERMATOLOGY. 2025; : [doi:10.1111/pde.70084]

Carbonell, MM; Martínez, AG; Mariño, SFP; Morín, MG; Vigil, CR; Ropero, P; Cela, E; Montañés, A; Recasens, V.

Unlocking Rare Diagnoses: The Essential Role of Molecular Techniques in Hemoglobin Agrinio. A Case Report

EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; : [doi:10.1111/ejh.70050]

Escribano-Serrat, S; Salas, MQ; Pascual-Izquierdo, C; Villalobos, MF; Gomez-Seguí, I; Fidalgo, T; Docampo, MF; Nieto, JM; Lamas, O; Lozano, M; Cid, J; Charry, P; Pino, M; Molina, P; De Moner, B; Ramos, A; Moreno-Castaño, AB; Martinez-Sanchez, J; Escolar, G; Díaz-Ricart, M.

EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura

Frontiers in Immunology. 2025; 16: Nº de citas: 4 [doi:10.3389/fimmu.2025.1700907]

Baena-Nuevo, M; Vera-Zambrano, A; Martinez-Laperche, C; Buño, I; Munoz-Calleja, C; Valenzuela, C; Zapata, JM; Perez-Chacon, G.

Indole-3-carbinol is an inhibitor of KV1.3 potassium voltage-gated channel activity in chronic lymphocytic leukemia cells

European Journal of Pharmacology. 2025; 1007: [doi:10.1016/j.ejphar.2025.178281]

Agulló, C; Puig, N; Varo, N; Iglesias, MA; Mugueta, C; Pello, R; Paiva, B; Martínez-López, J; Castro, S; Cárdenas, MC; García-Sanz, R; Pérez-Surribas, D; Flores-Montero, J; Ortiz-Espejo, M; de la Rubia, J; Cruz-Iglesias, E; Fontán, A; Isidoro-García, M; San-Miguel, J; Mateos, MV.

Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish society of laboratory medicine and the Spanish society of hematology and hemotherapy. Part III: clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometry

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2025; 64(3): 586-599 Nº de citas: 2 [doi:10.1515/cclm-2025-1056]

Rosa, AA; Carolina, AP; Marta, AV; Francisco, A; Adriana, FG; Natalia, G; Pablo, LL; Cristina, MF; Lidia, MS; Ulrike, N; Marina, S; Guillermo, HT; Henar, CG; Ana, GOD.

Desmoid Tumors-Experience from a Referral Center, Part 1: Multidisciplinary Review and Practical Recommendations

Cancers. 2025; 17(21): Nº de citas: 3 [doi:10.3390/cancers17213470]

Gutierrez, A; Zeberio, I; Penalver, FJ; Martinez-Barranco, P; Perez, S; Morillo, D; Martin, X; Nicolas, C; Ferrero, A; Jimenez-Ubieto, A; Bastos-Oreiro, M; Davila-Valls, J; Calle, MV; Perez, M; Rodriguez, G; Alonso, A; Garcia-Noblejas, A; Argüello, DS; Knight, T; Fernandez, A; Lopez, J; Oteyza, JPD; Villambrosia, SGD; Perez, E; Marin, A; Navarro, MB; Fernandez, R; Gomez, P; Hueso, JA; Ponce, MJP; Bravo, P; Garcia-Belmonte, D; De La Nuez, H; Nistal, S; Abrisqueta, P; Iban, F; Palomera, L; Donato, E; Provencio, A; Infante, MS; Gonzalez-Barca, E.

Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO

Blood Advances. 2025; 9(19): 4924-4935 Nº de citas: 2 [doi:10.1182/bloodadvances.2025016661]

Palmerini, E; Meazza, C; Tamburini, A; Márquez-Vega, C; Bisogno, G; Fagioli, F; Ferraresi, V; Milano, GM; Coccoli, L; Rubio-San-Simón, A; Gallego, O; Riestra, MEL; Manzitti, C; Mora, J; Vaz-Salgado, MA; Luksch, R; Mata, C; Pierini, M; Carretta, E; Cesari, M; Paioli, A; Marrari, A; Scotlandi, K; Serra, M; Asaftei, SD; Gambarotti, M; Picci, P; Ferrari, S; Valverde, C; Ibrahim, T; Broto, JM.

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials

JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(28): Nº de citas: 6 [doi:10.1200/JCO-25-00210]

Puga, B; Bass, F; Molina, J; Benavente, R; Andrade, A; Majlis, A; Cabrera, ME; Kwon, M.

Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in the public Chilean national health system: A single center study

Hematology Transfusion and Cell Therapy. 2025; 47(4): [doi:10.1016/j.htct.2025.103982]

Encinas, C; Blanchard, MJ; Fernández, RA; Hernández-Rivas, JA; Tamayo, RR; Machado-Vílchez, M; Martínez-López, J; Mateos, MV.

Factors Increasing the Risk of Infection in Patients With Multiple Myeloma: From Biology to Prevention

Clinical Lymphoma Myeloma & Leukemia. 2025; 25(10): Nº de citas: 1 [doi:10.1016/j.clml.2025.06.012]

Gallego-Valle, J; Pérez-Fernández, VA; Pita, A; Rosales-Magallares, J; López-Esteban, R; Gil-Manso, S; Carbonell, D; Pérez-Caballero, R; Pardo, C; Gil-Jaurena, JM; Correa-Rocha, R; Pion, M.

Enhancing specific thymic Treg activation and function with 4-1BB monomeric streptavidin-based CARs

Translational Research. 2025; 284: 1-16 [doi:10.1016/j.trsl.2025.09.004]

Fidalgo, AP; Alonso, P; Andión, M; Cañete, A; Collado, E; Colino, CG; Codina, JG; Carrasco, XD; Sanz, RG; Expósito, SH; Lopez-Fernandez, T; Medin, G; Molinés, A; Vega, AM; Ramos, M; Miguel, IS; García, JS; Santolaya, F.

Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain

Clinical & Translational Oncology. 2025; : [doi:10.1007/s12094-025-04047-0]

Martinez-Picado, J; Kwon, M; Salgado, M.

The power of ten in HIV remission: insights from hematopoietic stem cell transplantation

Current Opinion in HIV and AIDS. 2025; 20(5): 456-462 Nº de citas: 5 [doi:10.1097/COH.0000000000000954]

Foran, JM; Sanz, GF; Watts, JM; Brunner, AM; Fossard, G; Della Porta, MG; Tsai, XCH; Garcia-Manero, G; Dimicoli-Salazar, S; Fletcher, L; Kim, YJ; Font, P; Alfonso-Piérola, A; Alonso-Dominguez, JM; Benton, C; Hong, J; Malcovati, L; Mazure, D; Lee, JH; Yeh, SP; Goursaud, L; Barcellini, W; Wu, E; Corzo, D; Kuida, K; Stone, RM.

Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B-8800 in lower-risk myelodysplastic syndrome

LEUKEMIA RESEARCH. 2025; 156: Nº de citas: 5 [doi:10.1016/j.leukres.2025.107735]